Literature DB >> 3080143

Detection of lymphocytotoxic antibodies in relatives of patients with type I diabetes.

J A Charlesworth, P Peake, L V Campbell, J Rumma, B A Pussell, N Howard, G J Elder.   

Abstract

Concentrations of lymphocytotoxic antibodies were measured in serum samples from 19 patients recently diagnosed as having type I diabetes and 43 healthy relatives (33 consanguineous and 10 non-consanguineous). The specificity of the reaction was tested at 15 degrees C and 37 degrees C against T lymphocytes and purified helper/inducer and cytotoxic/suppressor subsets. The concentrations of lymphocytotoxic antibodies in each of the three test groups were significantly higher than those in controls (type I patients, p less than 0.005; consanguineous relatives, p less than 0.001; and non-consanguineous relatives, p less than 0.002). The frequency of detection of the antibodies was also greater in each of the study groups (p less than 0.01, p less than 0.01, and p less than 0.05, respectively). Cytotoxicity affected both subsets at 15 degrees C but only cytotoxic/suppressor cells at 37 degrees C. The findings of lymphocytotoxic antibodies in healthy relatives of type I diabetics, irrespective of consanguinity, suggests that an environmental agent such as a virus is at least partially responsible for this lymphocytotoxic effect. Furthermore, the residual cytotoxic/suppressor cell killing at 37 degrees C could explain the defect of suppressor cells observed in these patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080143      PMCID: PMC1339274          DOI: 10.1136/bmj.292.6516.292

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus.

Authors:  R J DeHoratius; R P Messner
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  Lymphotoxic activity in multiple sclerosis serum.

Authors:  S Van den Noort; R L Stjernholm
Journal:  Neurology       Date:  1971-08       Impact factor: 9.910

3.  Model for quantitative and qualitative control of mRNA translation in eukaryotes.

Authors:  M Sussman
Journal:  Nature       Date:  1970-03-28       Impact factor: 49.962

4.  Heterogeneity of antilymphocyte antibody in SLE and its correlation with disease activity.

Authors:  K Okudaira; K Tanimoto; T Aikawa; Y Horiuchi; S Aotsuka
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

5.  Lymphocytotoxins in infectious mononucleosis: a non-cytotoxic effect on lymphocytes at 37 degrees C and the influence of cell metabolism on their cytotoxicity in vitro.

Authors:  J W Quin; J A Charlesworth; D Yasmeen; G J Macdonald; B A Pussell
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

6.  Association of cold-reactive antilymphocyte antibodies with lymphopenia in systemic lupus erythematosus.

Authors:  J B Winfield; R J Winchester; H G Kunkel
Journal:  Arthritis Rheum       Date:  1975 Nov-Dec

7.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Studies of lymphocytotoxins in infectious mononucleosis: reduced lymphocyte killing in the acute phase.

Authors:  J W Quin; J A Charlesworth; C H Lee; G J Macdonald
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

9.  Immunological suppressor cell activity in insulin dependent diabetes.

Authors:  L M Slater; S L Murray; A Kershnar; M A Mosier
Journal:  J Clin Lab Immunol       Date:  1980-03

10.  Defective suppressor cell generation in juvenile onset diabetes.

Authors:  M M Lederman; J J Ellner; H M Rodman
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

View more
  3 in total

1.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Cell surface antibodies in type 1 (insulin-dependent) diabetic patients. II. Presence of immunoglobulins M which bind to lymphocytes.

Authors:  O Segers; F Gorus; G Somers; M Van de Winkel; M Vercammen; D Pipeleers
Journal:  Diabetologia       Date:  1989-08       Impact factor: 10.122

3.  Occurrence of lymphocytotoxins in multi-case rheumatoid arthritis families: relation to HLA.

Authors:  V Taneja; N K Mehra; R R Singh; C Anand; A N Malaviya
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.